8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Apr 30, 2026·SEC
Material company update
Mar 27, 2026·SEC
Teleflex Incorporated(TFX)Earnings, Financials & Key Ratios
TFX•NYSE
Price updated Jun 19, 2026
AboutTeleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.Show more
- Revenue$1.99B-34.6%
- EBITDA$434M+1.9%
- Net Income-$906M-1399.8%
- EPS (Diluted)-20.25-1468.2%
- Gross Margin56.24%+0.7%
- EBITDA Margin21.76%+55.8%
- Operating Margin12.84%+159.0%
- Net Margin-45.45%-2087.7%
- ROE-24.47%-1630.9%
TFX Key Insights
Teleflex Incorporated (TFX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 5.0% through buybacks
✗Weaknesses
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when TFX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
TFX Price & Volume
Teleflex Incorporated (TFX) stock price & volume — 10-year historical chart
Loading chart...
TFX Growth Metrics
Teleflex Incorporated (TFX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years0.97%
5 Years-4.72%
3 Years-10.62%
TTM-6.61%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-775.29%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-819.24%
Return on Capital
10 Years6.94%
5 Years6.34%
3 Years4.65%
Last Year4.05%
TFX Recent Earnings
Teleflex Incorporated (TFX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$1.39+14.9%
$1.21
Rev
$548M+2.1%
$537M
Q1 2026
Feb 26, 2026Metric
Actual
Est
EPS
$1.93-48.3%
$3.73
Rev
$569M-38.1%
$919M
Q4 2025
Nov 6, 2025Metric
Actual
Est
EPS
$3.67+8.6%
$3.38
Rev
$913M-0.2%
$915M
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$3.73+11.0%
$3.36
Rev
$781M-12.5%
$893M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $1.39vs $1.21+14.9% | $548Mvs $537M+2.1% |
| Q1 2026 | Feb 26, 2026 | $1.93vs $3.73-48.3% | $569Mvs $919M-38.1% |
| Q4 2025 | Nov 6, 2025 | $3.67vs $3.38+8.6% | $913Mvs $915M-0.2% |
| Q3 2025 | Jul 31, 2025 | $3.73vs $3.36+11.0% | $781Mvs $893M-12.5% |
Based on last 12 quarters of dataView full earnings history →
TFX Peer Comparison
Teleflex Incorporated (TFX) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 ICU | 122.25M | 3.12 | -0.53 | 8.14% | -8.29% | -146.29% | 0.05 | |
 UTMD | 214.77M | 67.04 | 19.26 | -5.83% | 29.3% | 9.56% | 0.00 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 ANGO | 505.13M | 12.15 | -14.64 | -3.76% | -9.02% | -15.71% | ||
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 | |
 BAX | 10.27B | 19.89 | -11.37 | 5.72% | -9.7% | -16.5% | 1.64 |
Compare TFX vs Peers
Teleflex Incorporated (TFX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
TFX Income Statement
Teleflex Incorporated (TFX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.15B | 2.45B | 2.6B | 2.54B | 2.81B | 2.79B | 2.97B | 3.05B | 1.99B | 2.81B |
Revenue Growth % | 14.9% | 14.07% | 6% | -2.24% | 10.74% | -0.66% | 6.57% | 2.45% | -34.61% | -6.61% |
Cost of Goods Sold | 974.5M | 1.06B | 1.19B | 1.21B | 1.26B | 1.26B | 1.33B | 1.34B | 871.96M | 1.31B |
COGS % of Revenue | 45.4% | 43.45% | 45.71% | 47.78% | 44.85% | 45.14% | 44.63% | 44.13% | 43.76% | - |
Gross Profit | 1.17B▲ 0% | 1.38B▲ 18.1% | 1.41B▲ 1.8% | 1.32B▼ 6.0% | 1.55B▲ 17.0% | 1.53B▼ 1.2% | 1.65B▲ 7.6% | 1.7B▲ 3.4% | 1.12B▼ 34.2% | 1.5B▲ 0% |
Gross Margin % | 54.6% | 56.55% | 54.29% | 52.22% | 55.15% | 54.86% | 55.37% | 55.87% | 56.24% | 53.27% |
Gross Profit Growth % | 17.63% | 18.15% | 1.77% | -5.97% | 16.96% | -1.19% | 7.57% | 3.38% | -34.18% | - |
Operating Expenses | 784.73M | 984.9M | 981.75M | 901.81M | 921.51M | 1.03B | 1.14B | 1.55B | 864.95M | 1.32B |
OpEx % of Revenue | 36.56% | 40.23% | 37.83% | 35.54% | 32.8% | 36.95% | 38.35% | 50.92% | 43.41% | - |
Selling, General & Admin | 699.96M | 878.69M | 851.77M | 743.57M | 860.09M | 863.75M | 929.87M | 995.27M | 720.17M | 945.23M |
SG&A % of Revenue | 32.61% | 35.89% | 32.82% | 29.31% | 30.61% | 30.95% | 31.26% | 32.66% | 36.14% | - |
Research & Development | 84.77M | 106.21M | 113.86M | 119.75M | 130.84M | 153.82M | 154.35M | 161.67M | 144.78M | 188.87M |
R&D % of Revenue | 3.95% | 4.34% | 4.39% | 4.72% | 4.66% | 5.51% | 5.19% | 5.31% | 7.27% | - |
Other Operating Expenses | 0 | 0 | 16.13M | 38.49M | -69.42M | 13.79M | 56.4M | 394.72M | 0 | 3M |
Operating Income | 372.28M▲ 0% | 321.7M▼ 13.6% | 427.25M▲ 32.8% | 423.07M▼ 1.0% | 628.1M▲ 48.5% | 499.73M▼ 20.4% | 506.31M▲ 1.3% | 151.01M▼ 70.2% | 255.8M▲ 69.4% | 182.14M▲ 0% |
Operating Margin % | 17.35% | 13.14% | 16.46% | 16.67% | 22.36% | 17.9% | 17.02% | 4.96% | 12.84% | 6.48% |
Operating Income Growth % | 16.54% | -13.59% | 32.81% | -0.98% | 48.46% | -20.44% | 1.32% | -70.17% | 69.39% | - |
EBITDA | 527.54M | 531.68M | 641.32M | 650.32M | 865.46M | 730.32M | 748.43M | 425.61M | 433.54M | 329.16M |
EBITDA Margin % | 24.58% | 21.72% | 24.71% | 25.63% | 30.8% | 26.17% | 25.16% | 13.97% | 21.76% | 11.71% |
EBITDA Growth % | 20.62% | 0.79% | 20.62% | 1.4% | 33.08% | -15.62% | 2.48% | -43.13% | 1.86% | -40.93% |
D&A (Non-Cash Add-back) | 155.26M | 209.98M | 214.06M | 227.25M | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M | 167.64M |
EBIT | 367.46M | 322.65M | 420.17M | 424.23M | 616.44M | 500.18M | 519.09M | 159.02M | 124.78M | -256.11M |
Net Interest Income | -81.78M | -102.08M | -78.53M | -65.34M | -55.64M | -53.35M | -72.3M | -75.53M | -93.82M | -105.82M |
Interest Income | 771K | 944K | 1.74M | 1.16M | 1.33M | 912K | 12.78M | 8.01M | 6.4M | 7.37M |
Interest Expense | 82.55M | 103.02M | 80.27M | 66.49M | 56.97M | 54.26M | 85.08M | 83.54M | 100.22M | 113.19M |
Other Income/Expense | -87.37M | 23.2M | -87.35M | -65.34M | -68.63M | -53.81M | -72.3M | -75.53M | -231.25M | -501.72M |
Pretax Income | 284.91M▲ 0% | 219.63M▼ 22.9% | 339.9M▲ 54.8% | 357.73M▲ 5.2% | 559.47M▲ 56.4% | 445.92M▼ 20.3% | 434.01M▼ 2.7% | 75.48M▼ 82.6% | 24.55M▼ 67.5% | -319.58M▲ 0% |
Pretax Margin % | 13.27% | 8.97% | 13.1% | 14.1% | 19.91% | 15.98% | 14.59% | 2.48% | 1.23% | -11.37% |
Income Tax | 129.65M | 23.2M | -122.08M | 21.93M | 74.35M | 83M | 76.44M | 5.32M | -33.98M | -24.9M |
Effective Tax Rate % | 45.5% | 10.56% | -35.92% | 6.13% | 13.29% | 18.61% | 17.61% | 7.04% | -138.38% | 7.79% |
Net Income | 152.53M▲ 0% | 200.8M▲ 31.6% | 461.47M▲ 129.8% | 335.32M▼ 27.3% | 485.37M▲ 44.7% | 363.14M▼ 25.2% | 356.33M▼ 1.9% | 69.67M▼ 80.4% | -905.64M▼ 1399.8% | -1.01B▲ 0% |
Net Margin % | 7.11% | 8.2% | 17.78% | 13.22% | 17.28% | 13.01% | 11.98% | 2.29% | -45.45% | -35.89% |
Net Income Growth % | -35.74% | 31.65% | 129.81% | -27.34% | 44.75% | -25.18% | -1.88% | -80.45% | -1399.81% | -775.29% |
Net Income (Continuing) | 155.26M | 196.43M | 461.98M | 335.8M | 485.12M | 362.92M | 357.57M | 70.16M | 58.53M | -294.68M |
Discontinued Operations | 0 | 4.37M | -515K | -477K | 255K | 223K | -1.24M | -487K | -964.17M | -2.02M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 3.27▲ 0% | 4.29▲ 31.2% | 9.80▲ 128.4% | 7.09▼ 27.7% | 10.23▲ 44.3% | 7.68▼ 24.9% | 7.53▼ 2.0% | 1.48▼ 80.3% | -20.25▼ 1468.2% | -22.79▲ 0% |
EPS Growth % | -34.34% | 31.19% | 128.44% | -27.65% | 44.29% | -24.93% | -1.95% | -80.35% | -1468.24% | -819.24% |
EPS (Basic) | 3.39 | 4.39 | 9.99 | 7.21 | 10.38 | 7.74 | 7.58 | 1.49 | -20.30 | - |
Diluted Shares Outstanding | 46.66M | 46.8M | 47.09M | 47.29M | 47.43M | 47.31M | 47.3M | 47.09M | 44.72M | 44.26M |
Basic Shares Outstanding | 45M | 45.69M | 46.2M | 46.49M | 46.77M | 46.9M | 46.98M | 46.84M | 44.62M | 44.26M |
Dividend Payout Ratio | 40.15% | 30.96% | 13.61% | 18.85% | 13.11% | 17.57% | 17.93% | 91.2% | - | - |
TFX Balance Sheet
Teleflex Incorporated (TFX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 1.13B | 1.24B | 1.31B | 1.42B | 1.43B | 1.41B | 1.41B | 1.47B | 1.94B | 1.86B |
Cash & Short-Term Investments | 333.56M | 357.16M | 301.08M | 375.88M | 445.08M | 292.03M | 222.85M | 306.16M | 393.26M | 309.41M |
Cash Only | 333.56M | 357.16M | 301.08M | 375.88M | 445.08M | 292.03M | 222.85M | 290.19M | 393.26M | 309.41M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.97M | 0 | 0 |
Accounts Receivable | 345.88M | 366.29M | 418.67M | 395.07M | 383.57M | 408.83M | 443.47M | 459.5M | 345.58M | 365.53M |
Days Sales Outstanding | 58.82 | 54.61 | 58.88 | 56.84 | 49.83 | 53.47 | 54.42 | 55.04 | 63.3 | 59 |
Inventory | 395.74M | 427.78M | 476.56M | 513.2M | 477.64M | 578.51M | 626.22M | 600.13M | 404.39M | 380.86M |
Days Inventory Outstanding | 148.23 | 146.76 | 146.62 | 154.52 | 138.37 | 167.59 | 172.17 | 162.9 | 169.28 | 158.48 |
Other Current Assets | 47.88M | 72.48M | 97.94M | 115.44M | 117.28M | 125.08M | 107.47M | 101.88M | 775.53M | 803.87M |
Total Non-Current Assets | 5.05B | 5.04B | 5B | 5.73B | 5.44B | 5.52B | 6.13B | 5.63B | 5.01B | 4.92B |
Property, Plant & Equipment | 383M | 432.77M | 543.88M | 574.55M | 573.41M | 578.42M | 603.43M | 611.76M | 590.1M | 561.87M |
Fixed Asset Turnover | 5.60x | 5.66x | 4.77x | 4.42x | 4.90x | 4.83x | 4.93x | 4.98x | 3.38x | 4.31x |
Goodwill | 2.24B | 2.25B | 2.25B | 2.59B | 2.5B | 2.54B | 2.91B | 2.63B | 2.31B | 2.3B |
Intangible Assets | 2.38B | 2.33B | 2.16B | 2.52B | 2.29B | 2.31B | 2.5B | 2.27B | 1.52B | 1.49B |
Long-Term Investments | 3.3M | 2.7M | 0 | 0 | 0 | 11.91M | 0 | 0 | 11.19M | 40.28M |
Other Non-Current Assets | 43.24M | 32.28M | 52.45M | 41.8M | 69.1M | 77.45M | 98.94M | 102.62M | 565.82M | 565.93M |
Total Assets | 6.18B▲ 0% | 6.28B▲ 1.6% | 6.31B▲ 0.5% | 7.15B▲ 13.4% | 6.87B▼ 3.9% | 6.93B▲ 0.8% | 7.53B▲ 8.7% | 7.1B▼ 5.8% | 6.95B▼ 2.1% | 6.78B▲ 0% |
Asset Turnover | 0.35x | 0.39x | 0.41x | 0.35x | 0.41x | 0.40x | 0.39x | 0.43x | 0.29x | 0.39x |
Asset Growth % | 58.86% | 1.56% | 0.51% | 13.36% | -3.93% | 0.82% | 8.73% | -5.77% | -2.12% | -3.17% |
Total Current Liabilities | 483.88M | 582.46M | 563.05M | 540.03M | 680.12M | 581.49M | 606.75M | 649.36M | 762.03M | 728.05M |
Accounts Payable | 92.03M | 106.71M | 102.92M | 102.52M | 118.24M | 126.81M | 132.25M | 141.03M | 130.2M | 143.63M |
Days Payables Outstanding | 34.47 | 36.61 | 31.66 | 30.87 | 34.25 | 36.74 | 36.36 | 38.28 | 54.5 | 41.49 |
Short-Term Debt | 86.63M | 86.63M | 50M | 100.5M | 110M | 87.5M | 87.5M | 100M | 100M | 103.13M |
Deferred Revenue (Current) | 221.95M | 5.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 186.29M | 278.51M | 181.49M | 53.87M | 55.63M | 63.38M | 46.55M | 68.54M | 388.27M | 481.3M |
Current Ratio | 2.33x | 2.12x | 2.32x | 2.63x | 2.10x | 2.43x | 2.32x | 2.27x | 2.54x | 2.55x |
Quick Ratio | 1.51x | 1.39x | 1.47x | 1.68x | 1.40x | 1.43x | 1.29x | 1.34x | 2.01x | 2.03x |
Cash Conversion Cycle | 172.58 | 164.75 | 173.84 | 180.48 | 153.95 | 184.32 | 190.23 | 179.66 | 178.08 | 175.99 |
Total Non-Current Liabilities | 3.27B | 3.16B | 2.77B | 3.28B | 2.44B | 2.32B | 2.48B | 2.17B | 3.06B | 2.97B |
Long-Term Debt | 2.16B | 2.07B | 1.86B | 2.38B | 1.74B | 1.62B | 1.73B | 1.56B | 2.54B | 68.32M |
Capital Lease Obligations | 0 | 0 | 101.37M | 86.1M | 116.03M | 120.44M | 111.3M | 99.15M | 84.21M | 275.37M |
Deferred Tax Liabilities | 603.68M | 608.22M | 439.56M | 484.68M | 370.12M | 388.89M | 456.08M | 391.07M | 183.75M | 1.15B |
Other Non-Current Liabilities | 500.48M | 475.14M | 367.57M | 327.41M | 210.6M | 191.26M | 189.86M | 124.32M | 251.04M | 2.73B |
Total Liabilities | 3.75B | 3.74B | 3.33B | 3.82B | 3.12B | 2.91B | 3.09B | 2.82B | 3.82B | 3.7B |
Total Debt | 2.25B | 2.16B | 2.01B | 2.56B | 1.97B | 1.83B | 1.93B | 1.76B | 2.73B | 171.44M |
Net Debt | 1.92B | 1.8B | 1.71B | 2.19B | 1.52B | 1.54B | 1.7B | 1.46B | 2.33B | -137.97M |
Debt / Equity | 0.93x | 0.85x | 0.67x | 0.77x | 0.52x | 0.46x | 0.43x | 0.41x | 0.87x | 0.06x |
Debt / EBITDA | 4.26x | 4.06x | 3.13x | 3.94x | 2.27x | 2.51x | 2.57x | 4.12x | 6.29x | 0.52x |
Net Debt / EBITDA | 3.63x | 3.39x | 2.67x | 3.37x | 1.76x | 2.11x | 2.28x | 3.44x | 5.38x | -0.42x |
Interest Coverage | 4.45x | 3.13x | 5.23x | 6.38x | 10.82x | 9.22x | 6.10x | 1.90x | 1.24x | -2.26x |
Total Equity | 2.43B▲ 0% | 2.54B▲ 4.5% | 2.98B▲ 17.3% | 3.34B▲ 12.0% | 3.75B▲ 12.5% | 4.02B▲ 7.1% | 4.44B▲ 10.4% | 4.28B▼ 3.7% | 3.12B▼ 27.0% | 3.08B▲ 0% |
Equity Growth % | 13.61% | 4.5% | 17.3% | 11.99% | 12.54% | 7.12% | 10.42% | -3.67% | -26.96% | -73.29% |
Book Value per Share | 52.09 | 54.27 | 63.27 | 70.56 | 79.17 | 85.01 | 93.88 | 90.84 | 69.87 | 69.69 |
Total Shareholders' Equity | 2.43B | 2.54B | 2.98B | 3.34B | 3.75B | 4.02B | 4.44B | 4.28B | 3.12B | 3.08B |
Common Stock | 46.87M | 47.25M | 47.54M | 47.81M | 47.93M | 47.96M | 48.05M | 48.1M | 48.2M | 0 |
Retained Earnings | 2.29B | 2.43B | 2.82B | 3.1B | 3.52B | 3.82B | 4.11B | 4.12B | 3.15B | 0 |
Treasury Stock | -228.86M | -168.54M | -165.72M | -162.59M | -157.27M | -154.89M | -152.1M | -350.34M | -649.53M | 0 |
Accumulated OCI | -265.09M | -341.08M | -344.39M | -297.3M | -346.96M | -403.52M | -314.4M | -316.67M | -239.47M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TFX Cash Flow Statement
Teleflex Incorporated (TFX) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 419.88M | 437.38M | 439.52M | 436.41M | 651.42M | 342.14M | 510.64M | 635.74M | 340.68M | 314.25M |
Operating CF Margin % | 19.56% | 17.86% | 16.93% | 17.2% | 23.19% | 12.26% | 17.17% | 20.86% | 17.1% | - |
Operating CF Growth % | 2.79% | 4.17% | 0.49% | -0.71% | 49.27% | -47.48% | 49.25% | 24.5% | -46.41% | -205.91% |
Net Income | 152.53M | 200.8M | 461.47M | 335.32M | 485.37M | 363.14M | 356.33M | 69.67M | 58.53M | -1.01B |
Depreciation & Amortization | 155.26M | 209.98M | 214.06M | 227.25M | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M | 198.86M |
Stock-Based Compensation | 19.41M | 22.44M | 26.94M | 20.74M | 22.94M | 27.22M | 31.46M | 31.35M | 0 | 21.71M |
Deferred Taxes | -41.82M | -6.1M | -168.59M | -32.67M | -110.24M | -13.01M | -13.05M | 0 | -100.97M | -76.94M |
Other Non-Cash Items | 2.53M | 54.55M | 20.15M | -136.51M | -111.36M | -25.84M | 5.54M | 261.94M | 286.46M | 470.71M |
Working Capital Changes | 131.97M | -44.3M | -114.5M | 22.28M | 127.34M | -239.96M | -111.77M | -1.82M | -81.09M | -2.09M |
Change in Receivables | -11.04M | -23.41M | -59.79M | 44.75M | -600K | -38.46M | -15.76M | -27.95M | -85.53M | -105.43M |
Change in Inventory | -22.36M | -37.2M | -53.17M | -5.5M | -11.14M | -110.69M | -41.07M | 1.72M | 84.04M | 130M |
Change in Payables | 39M | 52.05M | 5M | -3.68M | 94.02M | -24.79M | -31.26M | 9.66M | -8.28M | 4.81M |
Cash from Investing | -1.83B | -196.39M | -73.48M | -837.78M | 156.74M | -257.94M | -621.23M | -99.36M | -849.19M | -895.18M |
Capital Expenditures | -70.9M | -80.8M | -102.69M | -90.69M | -71.62M | -79.19M | -91.44M | -126.43M | -95.24M | -84.02M |
CapEx % of Revenue | 3.3% | 3.3% | 3.96% | 3.57% | 2.55% | 2.84% | 3.07% | 4.15% | 4.78% | 2.99% |
Acquisitions | -1.76B | -117.15M | 10.88M | -766.43M | 220.32M | -186M | -588.92M | -120K | -825.14M | -831.77M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 6.33M | 1.55M | 18.33M | 19.34M | 19.15M | 22.24M | 63.13M | 27.2M | 76.19M | 15.49M |
Cash from Financing | 1.14B | -206.43M | -418.84M | 455.16M | -715.82M | -217.51M | 38.54M | -421.93M | 611.54M | 626.08M |
Debt Issued (Net) | 1.22B | -93.5M | -253.5M | 575M | -634.5M | -145.45M | 101.25M | -161.5M | 982.04M | 703.11M |
Equity Issued (Net) | 0 | 0 | 0 | 0 | 11.1M | 0 | 0 | -200M | -300M | -6.57M |
Dividends Paid | -61.24M | -62.16M | -62.83M | -63.22M | -63.65M | -63.79M | -63.9M | -63.54M | -60.27M | -60.13M |
Share Repurchases | 0 | 0 | -21.21M | 0 | 0 | -4.31M | 0 | -200M | -300M | -6.57M |
Other Financing | -21.43M | -50.77M | -102.51M | -56.62M | -28.77M | -8.27M | 1.19M | 3.12M | -10.23M | -10.34M |
Net Change in Cash | -210.23M▲ 0% | 23.6M▲ 111.2% | -56.08M▼ 337.6% | 74.8M▲ 233.4% | 69.2M▼ 7.5% | -153.05M▼ 321.2% | -69.19M▲ 54.8% | 104.8M▲ 251.5% | 73.68M▼ 29.7% | -11.15M▲ 0% |
Free Cash Flow | 348.98M▲ 0% | 356.58M▲ 2.2% | 336.83M▼ 5.5% | 345.71M▲ 2.6% | 579.8M▲ 67.7% | 262.95M▼ 54.6% | 419.2M▲ 59.4% | 509.31M▲ 21.5% | 245.44M▼ 51.8% | 249.02M▲ 0% |
FCF Margin % | 16.26% | 14.56% | 12.98% | 13.63% | 20.64% | 9.42% | 14.09% | 16.71% | 12.32% | 8.86% |
FCF Growth % | -1.79% | 2.18% | -5.54% | 2.64% | 67.71% | -54.65% | 59.42% | 21.5% | -51.81% | -48.1% |
FCF per Share | 7.48 | 7.62 | 7.15 | 7.31 | 12.23 | 5.56 | 8.86 | 10.81 | 5.49 | 5.63 |
FCF Conversion (FCF/Net Income) | 2.75x | 2.18x | 0.95x | 1.30x | 1.34x | 0.94x | 1.43x | 9.12x | -0.38x | -0.25x |
Interest Paid | 74.26M | 101.79M | 0 | 0 | 73.6M | 70.92M | 100.22M | 98.38M | 0 | 0 |
Taxes Paid | 49.14M | 65.61M | 0 | 0 | 108.61M | 162.05M | 114.21M | 164.9M | 0 | 0 |
TFX Key Ratios
Teleflex Incorporated (TFX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 6.68% | 8.08% | 16.72% | 10.62% | 13.69% | 9.34% | 8.42% | 1.6% | -24.47% | -28.27% |
Return on Invested Capital (ROIC) | 8.01% | 5.55% | 7.1% | 6.21% | 8.72% | 6.92% | 6.49% | 1.91% | 3.43% | 2.65% |
Gross Margin | 54.6% | 56.55% | 54.29% | 52.22% | 55.15% | 54.86% | 55.37% | 55.87% | 56.24% | 53.27% |
Net Margin | 7.11% | 8.2% | 17.78% | 13.22% | 17.28% | 13.01% | 11.98% | 2.29% | -45.45% | -35.89% |
Debt / Equity | 0.93x | 0.85x | 0.67x | 0.77x | 0.52x | 0.46x | 0.43x | 0.41x | 0.87x | 0.06x |
Interest Coverage | 4.45x | 3.13x | 5.23x | 6.38x | 10.82x | 9.22x | 6.10x | 1.90x | 1.24x | -2.26x |
FCF Conversion | 2.75x | 2.18x | 0.95x | 1.30x | 1.34x | 0.94x | 1.43x | 9.12x | -0.38x | -0.25x |
Revenue Growth | 14.9% | 14.07% | 6% | -2.24% | 10.74% | -0.66% | 6.57% | 2.45% | -34.61% | -6.61% |
Related:TFX Dividend History·TFX Revenue History·TFX Price History·TFX P/E History·TFX Financial Ratios·TFX Institutional Holders
TFX SEC Filings & Documents
Teleflex Incorporated (TFX) SEC filings — annual & quarterly reports (10-K, 10-Q)
TFX Frequently Asked Questions
Teleflex Incorporated (TFX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Teleflex Incorporated (TFX) reported $2.81B in revenue for fiscal year 2025. This represents a 202% increase from $931.2M in 1996.
Teleflex Incorporated (TFX) saw revenue decline by 34.6% over the past year.
Teleflex Incorporated (TFX) reported a net loss of $1.01B for fiscal year 2025.
Dividend & Returns
Yes, Teleflex Incorporated (TFX) pays a dividend with a yield of 1.06%. This makes it attractive for income-focused investors.
Teleflex Incorporated (TFX) has a return on equity (ROE) of -24.5%. Negative ROE indicates the company is unprofitable.
Teleflex Incorporated (TFX) generated $249.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.